Hejian Zou

8PUBLICATIONS
20CO-AUTHORS
AllergyForestry biomass and bioproductsRheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Exercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 30, 2026
SSGJ-613 Alleviates Pain and Reduces the Risk of Acute Flares in Patients With Gout: A Randomized, Double-Blind, Phase II Study.

|May 19, 2026
Efficacy and Safety of Firsekibart in Patients with Acute Gout Unsuitable for Standard Therapy: 48-Week Results from an Open-Label Extension of a Randomized Phase 3 Trial.

|Nov 07, 2025
Firsekibart as a Prophylactic Treatment for Acute Gout Flare in Participants Initiating Urate-Lowering Therapy: A Phase 2, Randomized, Open-Label, Multicenter, Active-Controlled Trial.

Yiyun Yu, Yu Xue, Jiankang Hu

|Aug 20, 2025
Efficacy and Safety of Firsekibart Compared to Etoricoxib for Gout Flares: A Phase 2, Multicenter, Open-label, Active-controlled, Randomized Non-inferiority Trial.

Ning Kong, Yu Xue, Li Mao

|Jun 21, 2024
Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial Spondyloarthritis.

Xiaoxia Zhu, Jiankang Hu, Dongzhou Liu

|Mar 27, 2024
Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis.

Minrui Liang, Nicholas Dickel, Andrea-Hermina Györfi

Pageof 2

Frequent Collaborators

2 joint publications

Yiyun Yu

1 joint publications

Wenjing Ye

1 joint publications

Xiaoxia Zhu

1 joint publications

Weiguo Wan